Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 19 3 2020
Statut: ppublish

Résumé

A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.

Identifiants

pubmed: 32127123
doi: 10.2807/1560-7917.ES.2020.25.8.2000170
pmc: PMC7055037
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2009 Jun 18;14(24):
pubmed: 19555598
N Engl J Med. 2006 Jul 6;355(1):31-40
pubmed: 16822994
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Clin Infect Dis. 2005 Apr 1;40(7):1068-9
pubmed: 15825009
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62
pubmed: 20798667

Auteurs

Licia Bordi (L)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

Emanuele Nicastri (E)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

Laura Scorzolini (L)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

Antonino Di Caro (A)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

Maria Rosaria Capobianchi (MR)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

Concetta Castilletti (C)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

Eleonora Lalle (E)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
The participating members of INMI COVID-19 study group and Collaborating Centers are acknowledged at the end of the article.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH